CD154 signaling regulates the Th1 response to herpes simplex virus-1 and inflammation in infected corneas.
Approximately 7 days after HSV-1 corneal infection, BALB/c mice develop tissue-destructive inflammation in the cornea termed herpes stromal keratitis (HSK), as well as periocular skin lesions that are characterized by vesicles, edema, and fur loss. CD4(+) T cells and Th1 cytokines contribute to both the immunopathology in the cornea and the eradication of viral replication in the skin. We demonstrate that disruption of CD40/CD154 signaling does not impact the initial expansion of CD4(+) T cells in the draining lymph nodes, but dramatically reduces the persistence and Th1 polarization of these cells. Despite the reduced Th1 response, CD154(-/-) mice developed HSK and periocular skin disease with similar kinetics and severity (as assessed by clinical examination) as wild-type (WT) mice. However, when the composition of the inflammatory infiltrate was examined by flow cytometric analysis, CD154(-/-) mice exhibited significantly fewer CD4(+) and CD8(+) T cells and neutrophils than WT mice at the peak of HSK. Moreover, CD4(+) T cells from infected corneas of CD154(-/-) mice produced significantly less IFN-gamma than those of WT mice when stimulated with viral Ags in vitro. The IFN-gamma production of cells from infected corneas of WT mice was not affected by addition of anti-CD154 mAb to the stimulation cultures. This suggests that CD154 signaling is required at the inductive phase, but not at the effector phase, of the Th1 response within the infected cornea. We conclude that local disruption of CD40/CD154 signaling is not likely to be a useful therapy for HSK.
Xu
Min
M
Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Lepisto
Andrew J
AJ
Hendricks
Robert L
RL
D000818:Animals; D019013:CD40 Antigens / Q000378:metabolism; D023201:CD40 Ligand / Q000235:genetics / Q000378:metabolism*; D003315:Cornea / Q000276:immunology*; D004195:Disease Models, Animal; D006561:Herpes Simplex / Q000276:immunology* / Q000378:metabolism / Q000503:physiopathology; D018259:Herpesvirus 1, Human / Q000276:immunology*; D007371:Interferon-gamma / Q000378:metabolism; D051379:Mice; D017193:Skin Diseases, Viral / Q000503:physiopathology; D018417:Th1 Cells / Q000276:immunology* / Q000378:metabolism; D013997:Time Factors
D019013:CD40 Antigens; D023201:CD40 Ligand; D007371:Interferon-gamma